ISPC logo

ISPECIMEN INC

ISPCNASDAQ
🏆 #5513 by market capUS Equity
$1.19▼ $0.01 (−0.83%)
Live
🔔
Track ISPC
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 0.8%
7d▼ 5.6%
14d▼ 10.9%
30d▼ 23.0%
ytd▼ 89.5%
1y▼ 97.5%
🏦Market Cap
$165,245
Small Cap
📈Revenue Growth (YoY)
-79.2%
Declining
📊Gross Margin
-151.5%
Thin
💵FCF Margin
-1716.5%
Thin
⚖️P/S Ratio
0.4x
Cheap
Otter Score
56
Weak

Trading Snapshot

Day Range
$1.18 – $1.21
52-Week Range
$1.18 – $53.20
Volume
$2.93B
Avg Volume
$2.43B
Shares Outstanding
138,861
Next Earnings
Oct 26, 2026

Fundamentals Snapshot

Annual Revenue
$2M
Last Q Revenue
$151,940
P/E Ratio
-0.0
P/S Ratio
0.4x
EPS (TTM)
$-8.19
Dividend Yield
0.00%
Dilution (1yr)
+780.2%

Why Investors Own ISPC

  • ✓High-growth profile — revenue up +54.9% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 33% gross margin and 9% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ISPC logo

ISPECIMEN INC

ISPC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$2M▼ −79.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
1.2%▼ −97.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$9M▼ −29.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$4M▼ −48.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
212K▲ +780.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$7M▲ +$5M YoY
StockOtter · stockotter.space

About ISPECIMEN INC

iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
56/100

Analyst Price Target

ⓘ
Average Target
$1.17
▼ −1.3% Downside
High Target$1.37
Low Target$1.03
Based on 23 analysts

Latest News & Updates

🚀
CNBC·2h ago

ISPECIMEN INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Reuters·5h ago

Analysts lift ISPC price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Bloomberg·1d ago

ISPECIMEN INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.